Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding
Eye-area products with lower concentrations often work well for the similarly delicate lip border region
The peptide is currently sold for research purposes only and lacks FDA approval for human therapeutic use
These signals support biologic plausibility and justify further translational investigation, but do not establish clinical benefit
They include: Pain, redness, or swelling at the injection site Mild diarrhea or nausea Itching or skin irritation near the injection area A sensation of swelling throughout the body Headache or dizziness These effects typically resolve within 24 to 48 hours and do not require medical intervention
The peptide does not affect blood pressure, heart rate, or cardiovascular parameters in studies